Addressing a Key Challenge in Veterinary Medicine
Biofilms are one of the greatest obstacles in treating infections, forming protective layers that resist traditional treatments. Dental plaque, a rapidly forming biofilm on teeth and gums, quickly becomes imbalanced (dysbiotic), enabling harmful microbes to thrive and cause oral diseases like periodontal disease, gingivitis, and cavities. By age three, this leads to periodontal disease in 70% of cats and 80% of dogs, making effective plaque management crucial.
Traditional approaches—such as daily brushing, oral fresheners, or dental wipes—provide only temporary relief, lasting mere hours to a day. In contrast, our flagship product, GingiGuard Gel, disrupts these biofilms directly, preventing plaque dysbiosis with just one easy, monthly application. This innovative approach reduces the need for frequent interventions, lowers the risk of oral diseases, and helps combat antimicrobial resistance by minimizing antibiotic usage.
Proven Safety and Effectiveness
GingiGuard Gel has demonstrated the ability to safely and effectively disrupt biofilms in laboratory and animal studies, targeting microbes like MRSA, Candida, and Porphyromonas, which are common in oral infections. By selectively blocking key microbes, GingiGuard Gel breaks down harmful plaque and prevents its reformation.
In one case study, a Belgian Malinois with advanced periodontal disease saw improvement after a single application, with the treatment remaining active for over 30 days.
Efficiency and Savings
Expanding the Product Line
Beyond oral care, Saint Roch Veterinary’s biofilm-disrupting technology platform is being developed to treat ear infections, wounds, and eye conditions in companion animals. Clinical trials are underway for equine eye fungal disease and mare infertility, expanding our reach into other segments of veterinary medicine.